Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications
Read More
Author: PharmaTimes
TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform
TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno...
Read More
Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain
Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the...
Read More
4 ways AI is shaping the future of Life Sciences
There’s no denying it; pharma is in its innovation era. The life sciences industry is already...
Read More
Acelyrin’s izokibep for hidradenitis suppurativa reveals positive results
However the company will not continue developing the candidate
Read More- ErVimmune raises 17m euros in funding to develop cancer vaccine
- Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
